Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)

অনুরূপ উপাদানগুলি

• Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long-term open-label adalimumab treatment: 3-year results of the ABILITY-1 trial
  অনুযায়ী: van der Heijde, Désirée, অন্যান্য
  প্রকাশিত: (2018)
• Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: a comparison by systematic literature review and meta-analysis
  অনুযায়ী: López-Medina, Clementina, অন্যান্য
  প্রকাশিত: (2019)
• Predictors of remission in patients with non-radiographic axial spondyloarthritis receiving open-label adalimumab in the ABILITY-3 study
  অনুযায়ী: Sieper, Joachim, অন্যান্য
  প্রকাশিত: (2019)
• Predictors of remission in patients with non-radiographic axial spondyloarthritis receiving open-label adalimumab in the ABILITY-3 study
  অনুযায়ী: Robert Landewé, অন্যান্য
  প্রকাশিত: (2019-06-01)
• Randomized Controlled Trial of Adalimumab in Patients With Nonpsoriatic Peripheral Spondyloarthritis
  অনুযায়ী: Mease, Philip, অন্যান্য
  প্রকাশিত: (2015)